SNRPG Human

Small Nuclear Ribonucleoprotein Polypeptide G Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Functions and Interactions

SNRPG is a member of the Sm protein family, essential for small nuclear ribonucleoprotein (snRNP) assembly and spliceosome activation . Key interactions include:

  • DDX20 (Gemini-2): Regulates snRNP biogenesis .

  • TACC1: Implicated in transcriptional regulation and cancer progression .

Functional Pathways:

  • Pre-mRNA splicing via U1, U2, U4, U5 snRNP complexes .

  • Histone mRNA 3'-end processing through U7 snRNP .

Autoimmunity

SNRPG is a target of anti-Sm autoantibodies in systemic lupus erythematosus (SLE), serving as a diagnostic marker .

Cancer Prognosis and Mechanisms

SNRPG overexpression correlates with poor outcomes in multiple cancers:

Cancer TypeRole of SNRPGMechanismCitation
Hepatocellular Carcinoma (HCC)High mRNA/protein expression linked to advanced TNM stages and reduced survival .Activates mTOR signaling and inhibits autophagy .
Glioblastoma (GBM)Suppression induces cell cycle arrest and sensitizes cells to temozolomide .Targets Myc via p53-dependent pathways .
Lung Adenocarcinoma (LUAD)Upregulation associated with smoking-related tumor progression .Synergizes with SNRPB/D1/D2/D3/E/F in spliceosome dysregulation .

Key Findings:

  • SNRPG knockdown in GBM promotes autophagy (↑ LC3-I/II ratio, Atg5/7/12 expression) .

  • In HCC, SNRPG co-expresses with SNRPA, SNRPB, and SNRPE (r > 0.67, p < 0.05), driving ribosome and cell cycle pathways .

Expression Profiles

Normal Tissues:

  • Ubiquitous expression, highest in metabolically active organs (liver, kidney) .

Cancer vs. Normal:

  • Elevated in 28/33 tumors (TCGA/GTEx data), including HCC, LUAD, and glioblastoma .

  • Protein overexpression confirmed in 17/21 tumors (Immunohistochemistry) .

Therapeutic Implications

Targeting SNRPG in Cancer:

  • Glioblastoma: SNRPG suppression enhances temozolomide efficacy via p53-Myc axis .

  • HCC: SNRPG-associated pathways (ribosome biogenesis, DNA repair) are druggable vulnerabilities .

Challenges:

  • Functional redundancy within the Sm protein family may limit single-target efficacy .

Research Tools and Reagents

Recombinant SNRPG Applications:

  • Antibody production (anti-Sm autoantibody studies) .

  • In vitro spliceosome assembly assays .

Product Specs

Introduction
Small nuclear ribonucleoprotein polypeptide G (SNRPG) belongs to the snRNP Sm proteins family, encompassing at least 7 isoforms: B/B, E, F, G, D1, D2, and D3. These proteins play a crucial role in snRNP biogenesis. Human Sm G genes are located on chromosome 2. Notably, these proteins are primary targets for anti-Sm autoantibodies, which serve as diagnostic markers for systemic lupus erythematosus (SLE). A specific class of these autoantibodies exhibits reactivity towards native Sm E-F-G complexes.
Description
Recombinant human SNRPG, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein comprises 96 amino acids (including a 20 amino acid His tag at the N-terminus, spanning residues 1-76) and has a molecular weight of 10.6 kDa. Purification of SNRPG is achieved using proprietary chromatographic methods.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
SNRPG is provided as a 1 mg/ml solution in 20mM Tris-HCl buffer (pH 8.0), 1mM DTT, 50% glycerol, and 0.1M NaCl.
Stability
For short-term storage (up to 2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95.0% as determined by SDS-PAGE analysis.
Synonyms
Small nuclear ribonucleoprotein G, snRNP-G, Sm protein G, Sm-G, SmG, SNRPG, PBSCG, MGC117317.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MSKAHPPELK KFMDKKLSLK LNGGRHVQGI LRGFDPFMNL VIDECVEMAT SGQQNNIGMV VIRGNSIIML EALERV.

Q&A

What is SNRPG and what are its primary cellular functions?

SNRPG (small nuclear ribonucleoprotein polypeptide G) is a protein-coding gene that contributes to RNA binding activity and is primarily involved in mRNA splicing via the spliceosome. It plays a critical role in RNA splicing and mRNA processing pathways . The protein is predicted to be located in the nucleus and functions as part of the SMN-Sm protein complex. SNRPG is also predicted to be active in P granules, which are cytoplasmic RNA-protein complexes involved in post-transcriptional regulation .

What is the genomic location and structure of the SNRPG gene?

In zebrafish (as a model organism), SNRPG is located on chromosome 23 . In humans, the gene encodes a small protein that contains several conserved domains including:

  • LSM domain superfamily

  • Small nuclear ribonucleoprotein G

  • Sm domain

  • Sm domain, eukaryotic/archaea-type

  • Sm-like protein Lsm7/SmG

The protein product is relatively small, with variants of approximately 70-76 amino acids in length as observed in some model systems .

How has SNRPG been validated as a reference gene for RT-qPCR analysis?

SNRPG has been identified and validated as one of four stable reference genes (along with OST4, TOMM7, and NOP10) for normalizing RT-qPCR data in extracellular vesicle (EV) research . The validation process included:

  • Testing the stability of SNRPG expression across multiple cell lines and their secreted EVs (n=12) under various physiological and pathological conditions

  • Confirming its presence in human-derived biofluids (n=3)

  • Verifying through enzymatic treatments that SNRPG is located inside EVs rather than merely associated with their surface

  • Demonstrating stable detection across a range of EV subpopulations

RefFinder analysis revealed that SNRPG, OST4, TOMM7, and NOP10 exhibit greater stability compared to traditional reference genes such as HMBS, YWHAZ, SDHA, and GAPDH that were established specifically for cultured cells or tissues .

What methodological considerations should be taken when using SNRPG as a reference gene?

When employing SNRPG as a reference gene for RT-qPCR normalization in EV studies, researchers should:

  • Verify the stability of SNRPG expression in their specific experimental system before proceeding with normalization

  • Consider the combination of multiple reference genes (SNRPG, OST4, TOMM7, and NOP10) for more robust normalization

  • Implement appropriate controls to account for potential contamination in EV isolates

  • Perform enzymatic treatments to confirm that the RNA is truly encapsulated within EVs

  • Consider the influence of different (patho)physiological conditions on reference gene stability

This methodological approach helps mitigate issues related to experimental design and confounding factors that can lead to spurious associations, a common problem in genetic research as highlighted in various studies .

What is the relationship between SNRPG expression and glioblastoma multiforme (GBM)?

SNRPG expression has been found to be significantly upregulated in human glioblastoma multiforme (GBM) tissues compared to normal brain tissue, as documented in The Cancer Genome Atlas (TCGA) dataset . Specifically:

  • Statistical analysis using R programming language confirmed significant upregulation of SNRPG in GBM tissues (FC = 2.46, P = 3.86E-16)

  • Independent verification via RT-qPCR in 15 GBM tissues and non-tumor tissues corroborated these findings

  • Kaplan-Meier survival analyses of GBM patients with different levels of SNRPG expression revealed a correlation with patient outcomes, suggesting potential prognostic value

How does SNRPG modulation affect cancer cell behavior?

Research has demonstrated that downregulation of SNRPG can induce cell cycle arrest and sensitize GBM cells to temozolomide (TMZ), a standard chemotherapeutic agent used in GBM treatment . The mechanism appears to involve:

  • Suppression of SNRPG sensitizing GBM cells to TMZ by targeting Myc via the p53 signaling cascade

  • Alterations in multiple cellular pathways including cell cycle regulation, cellular assembly, development, movement, and cell death/survival

A gene expression profile analysis revealed numerous downstream targets affected by SNRPG modulation, suggesting its potential role in multiple cancer-related pathways including:

  • Cell cycle regulation

  • Cellular assembly and organization

  • Cellular development and movement

  • Cell death and survival

  • DNA replication

  • Organismal survival

What are critical factors to consider in experimental design when studying SNRPG?

Proper experimental design is crucial for obtaining reliable results when studying SNRPG. Key considerations include:

  • Randomization of samples: Ensure that data collection and experimental order (e.g., plating) are randomized with respect to phenotypes of interest to avoid confounding effects

  • Batch effect control: Be vigilant about batch effects, particularly when combining multiple experiments (mega-analyses)

  • Appropriate controls: Include suitable positive and negative controls when assessing SNRPG function or expression

  • Validation across different models: Verify findings across multiple cell lines or tissue types to ensure generalizability

Failing to address these factors can lead to spurious associations and experimental artifacts, as observed in numerous genetic studies where approximately 95% had major problems with experimental design .

What techniques are most effective for studying SNRPG function in RNA processing?

To investigate SNRPG's role in RNA processing, researchers should consider:

  • RNA-seq analysis: To identify global changes in splicing patterns following SNRPG modulation

  • Co-immunoprecipitation (Co-IP): To identify protein interaction partners within the spliceosome complex

  • Chromatin immunoprecipitation (ChIP): To study potential DNA-protein interactions

  • CRISPR-Cas9 gene editing: For precise manipulation of SNRPG expression or function

  • RT-qPCR with specific primer design: For detecting alternatively spliced transcripts, using the validated normalization approach with SNRPG, OST4, TOMM7, and NOP10 as reference genes

Why are stable reference genes like SNRPG important for EV research?

  • The absence of universal and stably present reference genes has hampered the application of RT-qPCR in EV studies

  • Traditional reference genes established for cells or tissues may not maintain stability in EVs

  • The small RNA content in EVs requires highly reliable normalization methods for accurate quantification

SNRPG, along with OST4, TOMM7, and NOP10, provides a solution by offering stable reference points that enable proper normalization of RT-qPCR data in EV research, facilitating both basic research and clinical applications .

How can SNRPG be used in biomarker development for clinical applications?

SNRPG's stable presence in EVs across various conditions makes it valuable for biomarker development:

  • Normalization standard: Using SNRPG as a reference gene allows for accurate quantification of potential biomarker transcripts in EVs

  • Quality control: SNRPG detection can serve as a quality indicator for EV RNA isolation

  • Baseline measurement: Establishing SNRPG levels in healthy individuals provides a baseline for comparison with disease states

  • Longitudinal monitoring: The stability of SNRPG expression enables reliable tracking of disease progression or treatment response over time

This approach is particularly relevant for liquid biopsy applications, where EVs from biofluids offer a non-invasive window into disease processes.

What are emerging areas of research regarding SNRPG beyond its canonical functions?

Recent investigations have begun to explore non-canonical roles of SNRPG:

  • Cancer biology: Beyond GBM, examining SNRPG's role in other cancer types could reveal common mechanisms of dysregulation

  • Therapeutic targeting: Exploring SNRPG as a potential therapeutic target, particularly in cancers where it is upregulated

  • Structural biology: Determining high-resolution structures of SNRPG-containing complexes to better understand its mechanistic functions

  • Developmental biology: Investigating the role of SNRPG in cellular differentiation and development

  • Systems biology: Mapping SNRPG's position in broader regulatory networks affecting RNA metabolism

How can contradictory findings about SNRPG function be reconciled in research?

When encountering contradictory findings about SNRPG function, researchers should:

  • Evaluate experimental contexts: Different cell types, developmental stages, or physiological conditions may explain divergent results

  • Consider technical variations: Different methodologies (knockout vs. knockdown, acute vs. chronic depletion) may yield different outcomes

  • Examine dose-dependency: SNRPG may have different effects at different expression levels

  • Explore compensatory mechanisms: Other spliceosomal components may compensate for SNRPG alterations in some systems but not others

  • Integrate multi-omics data: Combining transcriptomic, proteomic, and functional data can provide a more complete picture of SNRPG's role

Product Science Overview

Function and Importance

SNRPG is involved in the splicing of U12-type introns in pre-mRNAs and is also a part of the U7 snRNP, which participates in the processing of the 3’ end of histone transcripts . The protein encoded by this gene is essential for the proper functioning of the spliceosome, a complex responsible for removing introns from pre-mRNA transcripts .

Genetic Information

The SNRPG gene is located on chromosome 2 and has several transcript variants encoding different isoforms . It is associated with various pathways, including the processing of capped intron-containing pre-mRNA and capped intronless pre-mRNA . Diseases associated with SNRPG include Cardiomyopathy, Dilated, 1Dd, and Spinal Muscular Atrophy .

Research and Applications

Human recombinant SNRPG is used in various research applications to study its role in mRNA splicing and its involvement in different genetic pathways. Understanding the function and structure of SNRPG can provide insights into the mechanisms of gene expression regulation and the development of certain diseases.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.